Bioventus Gains FDA Clearance of SIGNAFUSE Bone Graft Strip
Bioventus received FDA 510(k) clearance to market SIGNAFUSE® Bioactive Bone Graft in a strip format. The strips consist of 55%...
Bioventus received FDA 510(k) clearance to market SIGNAFUSE® Bioactive Bone Graft in a strip format. The strips consist of 55%...
STIMULAN is the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft...
Osteo3 ZP Putty combines best-in-class bone repair with intraoperative ease-of-use for spine and trauma bone grafting applications....
Enrollment of the FORTIFY study on CERAMENT G has been completed, with 198 subjects enrolled. BONESUPPORT expects to submit a...
BONESUPPORT's bone graft substitutes are based on the patented CERAMENT technology platform. Direct sales commence in July 2020....
Results show that elderly patients undergoing non-instrumented fusion achieve statistically significantly higher fusion rates with i-FACTOR vs. allograft....
The JTA-004 Phase III study is approved in five of seven territories. These are the first patients treated after resumption...
Carmell will begin enrolling in a pivotal clinical program for Plasma-based Bioactive Material used in long-bone fractures as an adjunctive...
This represents the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft...
New preclinical data confirms that local delivery of a bisphosphonate in combination with CERAMENT can regenerate cancellous bone....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.